A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan

CompletedOBSERVATIONAL
Enrollment

979

Participants

Timeline

Start Date

July 8, 2019

Primary Completion Date

August 13, 2024

Study Completion Date

August 13, 2024

Conditions
Prostatic Neoplasms
Interventions
DRUG

Androgen-deprivation Therapy (ADT)

Participants enrolled in this study will continue to receive ADT (example- Leuprorelin, Goserelin and Degarelix) alone or in combination with other therapies in routine clinical practice as directed by their treating physician. No intervention will be administered as a part of this study.

DRUG

Bicalutamide

Participants enrolled in this study will continue to receive bicalutamide along with ADT in routine clinical practice as directed by their treating physician. No intervention will be administered as a part of this study.

DRUG

Abiraterone

Participants enrolled in this study will continue to receive abiraterone in combination with prednisolone along with ADT in routine clinical practice as directed by their treating physician. No intervention will be administered as a part of this study.

DRUG

Prednisolone

Participants enrolled in this study will continue to receive prednisolone in combination with abiraterone along with ADT in routine clinical practice as directed by their treating physician. No intervention will be administered as a part of this study.

DRUG

Docetaxel

Participants enrolled in this study will continue to receive docetaxel along with ADT in routine clinical practice as directed by their treating physician. No intervention will be administered as a part of this study.

DRUG

Enzalutamide

Participants enrolled in this study will continue to receive enzalutamide along with ADT in routine clinical practice as directed by their treating physician. No intervention will be administered as a part of this study.

DRUG

Apalutamide

Participants enrolled in this study will continue to receive apalutamide along with ADT in routine clinical practice as directed by their treating physician. No intervention will be administered as a part of this study.

Trial Locations (77)

1648541

Tokyo Metropolitan Police Hospital, Nakano

010-8543

Akita University Hospital, Akita

113 8431

Juntendo University Hospital, Bunkyō City

113 8519

Tokyo Medical and Dental University Hospital, Bunkyō City

260 8677

Chiba University Hospital, Chiba

260-8717

Chiba Cancer Center, Chiba

409-3898

University of Yamanashi Hospital, Chūō

807-8555

Hospital of the University of Occupational and Enviromental Health, Fukuoka

812 8582

Kyushu University Hospital, Fukuoka

960 1295

Fukushima Medical University Hospital, Fukushima

501-1194

Gifu University Hospital, Gifu

812-0033

Harasanshin Hospital, Hakata-Ku

431-3192

Hamamatsu University Hospital, Hamamatsu

350-1298

Saitama Medical University International Medical Center, Hidaka

036-8563

Hirosaki University Hospital, Hirosaki

734 8551

Hiroshima University Hospital, Hiroshima

272-8513

Tokyo Dental College Ichikawa General Hospital, Ichikawa

300 0395

Tokyo Medical University Ibaraki Medical Center, Inashiki

173 8606

Teikyo University Hospital, Itabashi Ku

920-0293

Kanazawa Medical University Hospital, Kahoku-District

602-8566

University Hospital Kyoto Prefectural University of Medicine, Kamigyo

216 8511

St Marianna University Hospital, Kanagawa

920 8641

Kanazawa University Hospital, Kanazawa

634-8522

Nara Medical University Hospital, Kashihara

292-8535

Kimitsu Chuo Hospital, Kisarazu-shi

761 0793

Kagawa University Hospital, Kita Gun

650 0017

Kobe University Hospital, Kobe

650 0047

Kobe City Medical Center General Hospital, Kobe

783-8505

Kochi Medical School Hospital, Kochi

343-8555

Dokkyo Medical University Saitama Medical Center, Koshigaya

791-0280

National Hospital Organization Shikoku Cancer Center, Matsuyama

252-0375

Kitasato University Hospital, Minamiku

889-1692

University of Miyazaki Hospital, Miyazaki

020-8505

Iwate Medical University Hospital, Morioka

480-1195

Aichi Medical University Hospital, Nagakute

852-8501

Nagasaki University Hospital, Nagasaki

467 8602

Nagoya City University Hospital, Nagoya

903-0215

University of the Ryukyus Hospital, Nakagami Gun

981-1293

Miyagi Cancer Center, Natori-shi

951 8520

Niigata University Medical And Dental Hospital, Niigata

700 8558

Okayama University Hospital, Okayama

541 8567

Osaka International Cancer Institute, Osaka

589 8511

Kindai University Hospital, Osaka Sayama Shi

373 8550

Gunma Prefectural Cancer Center, Ōta-ku

520-2121

Shiga University of Medical Science Hospital, Ōtsu

350-8550

Japan Community Health Care Organization Saitama Medical Center, Saitama

060-8543

Sapporo Medical University Hospital, Sapporo

060-8648

Hokkaido University Hospital, Sapporo

980 8574

Tohoku University Hospital, Sendai

981-8558

Tohoku Medical And Pharmaceutical University Hospital, Sendai

329-0498

Jichi Medical University Hospital, Shimotsuke

142 8666

Showa University Hospital, Shinagawa City

Unknown

Japan Community Health care Organization Tokyo Shinjuku Medical Center, Shinjuku-ku

436-0040

Chutoen General Medical Center, Shizuoka

565-0871

Osaka University Hospital, Suita-shi

569-8686

Osaka Medical and Pharmaceutical University Hospital, Takatsuki

770-8503

Tokushima University Hospital, Tokushima

105 8471

The Jikei University Hospital, Tokyo

105-8470

Toranomon Hospital, Tokyo

113 8603

Nippon Medical School Hospital, Tokyo

135 8550

The Cancer Institute Hospital of JFCR, Tokyo

160-0023

Tokyo Medical University Hospital, Tokyo

791-0295

Ehime University Hospital, Toon-shi

930-0194

Toyama University Hospital, Toyama

470-1192

Fujita Health University Hospital, Toyoake

514 8507

Mie University Hospital, Tsu

305 8576

University of Tsukuba Hospital, Tsukuba

755-8505

Yamaguchi University Hospital, Ube

641 8510

Wakayama Medical University Hospital, Wakayama

990-9585

Yamagata University Hospital, Yamagata

222-0036

Yokohama Rosai Hospital, Yokohama

232 0024

Yokohama City University Medical Center, Yokohama

236 0004

Yokohama City University Hospital, Yokohama

238 8558

Yokosuka Kyosai Hospital, Yokosuka

683-8504

Tottori University Hospital, Yonago

910-1193

University of Fukui Hospital, Yoshida

879-5593

Oita University Hospital, Yufu

Sponsors
All Listed Sponsors
lead

Janssen Pharmaceutical K.K.

INDUSTRY

NCT04034095 - A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in Japan | Biotech Hunter | Biotech Hunter